138 related articles for article (PubMed ID: 28988693)
1. Circulating CD8
Song Q; Ren J; Zhou X; Wang X; Song G; Hobeika A; Yuan Y; Lyerly HK
Cytotherapy; 2018 Jan; 20(1):126-133. PubMed ID: 28988693
[TBL] [Abstract][Full Text] [Related]
2. Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
Song G; Wang X; Jia J; Yuan Y; Wan F; Zhou X; Yang H; Ren J; Gu J; Lyerly HK
Cancer Immunol Immunother; 2013 Jun; 62(6):1123-30. PubMed ID: 23604172
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion.
Song QK; Ren J; Zhou XN; Wang XL; Song GH; Di LJ; Yu J; Hobeika A; Morse MA; Yuan YH; Yang HB; Lyerly HK
Oncotarget; 2015 Dec; 6(38):41350-9. PubMed ID: 26462021
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
5. Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.
Geng R; Tang H; You T; Xu X; Li S; Li Z; Liu Y; Qiu W; Zhou N; Li N; Ge Y; Guo F; Sun Y; Wang Y; Li T; Bai C
Front Immunol; 2023; 14():1125876. PubMed ID: 36969245
[TBL] [Abstract][Full Text] [Related]
6. ELEVATED PD-1/CD28 RATIO RATHER THAN PD-1 EXPRESSION IN CD8+ T CELLS PREDICTS NOSOCOMIAL INFECTION IN SEPSIS PATIENTS: A PROSPECTIVE, OBSERVATIONAL COHORT STUDY.
Zhong W; Li J; Li D; Li X; Liu M; Zhang T; Huang J; Huang G; Zeng H; Zhou M; Jiang W
Shock; 2022 Aug; 58(2):111-118. PubMed ID: 36166194
[TBL] [Abstract][Full Text] [Related]
7. Persistence of peripheral CD8 + CD28- T cells indicates a favourable outcome and tumour immunity in first-line HER2-positive metastatic breast cancer.
Liu X; Cheng X; Xie F; Li K; Shi Y; Shao B; Liang X; Wan F; Jia S; Zhang Y; Liu Y; Li H
Br J Cancer; 2024 Jun; 130(10):1599-1608. PubMed ID: 38519706
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Circulating CD28 Negative Suppressor T Cells and Memory B Cells in Patients with Breast Cancer.
Zahran AM; Shaltout AS; Fakhry H; Khallaf SM; Abdel Fattah ON; Temerik DF; Rayan A
Iran J Immunol; 2020 Jun; 17(2):95-110. PubMed ID: 32602464
[TBL] [Abstract][Full Text] [Related]
9. A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.
Alvarez-Fernández C; Escribà-Garcia L; Vidal S; Sierra J; Briones J
J Transl Med; 2016 Jul; 14(1):214. PubMed ID: 27435312
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer.
Kini Bailur J; Gueckel B; Pawelec G
J Transl Med; 2016 May; 14(1):151. PubMed ID: 27234566
[TBL] [Abstract][Full Text] [Related]
11. Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer.
Liu C; Hu Q; Hu K; Su H; Shi F; Kong L; Zhu H; Yu J
J Transl Med; 2019 Apr; 17(1):120. PubMed ID: 30971280
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced changes and immunosenescence of CD8+ T-cells in patients with breast cancer.
Onyema OO; Decoster L; Njemini R; Forti LN; Bautmans I; De Waele M; Mets T
Anticancer Res; 2015 Mar; 35(3):1481-9. PubMed ID: 25750301
[TBL] [Abstract][Full Text] [Related]
13. Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancer.
Liu XR; Yu JJ; Song GH; Di LJ; Jiang HF; Yan Y; Liang X; Zhang RY; Ran R; Wang J; Bai H; Jia SD; Li HP
Breast; 2021 Feb; 55():7-15. PubMed ID: 33296767
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
Lafrenie RM; Speigl L; Buckner CA; Pawelec G; Conlon MS; Shipp C
Clin Breast Cancer; 2019 Dec; 19(6):433-442. PubMed ID: 31383605
[TBL] [Abstract][Full Text] [Related]
15. Decreased level of peripheral CD8
Li Y; Qian T; Zhao H; Zhang Z; Ming Y; Qiao G; Liu J
Future Oncol; 2020 Nov; 16(32):2611-2617. PubMed ID: 32820651
[No Abstract] [Full Text] [Related]
16. Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
Bailur JK; Gueckel B; Derhovanessian E; Pawelec G
Breast Cancer Res; 2015 Mar; 17(1):34. PubMed ID: 25849846
[TBL] [Abstract][Full Text] [Related]
17. T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence.
Fagnoni FF; Lozza L; Zibera C; Zambelli A; Ponchio L; Gibelli N; Oliviero B; Pavesi L; Gennari R; Vescovini R; Sansoni P; Da Prada G; Robustelli Della Cuna G
Immunology; 2002 May; 106(1):27-37. PubMed ID: 11972629
[TBL] [Abstract][Full Text] [Related]
18. MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Li Y; Liu S; Hernandez J; Vence L; Hwu P; Radvanyi L
J Immunol; 2010 Jan; 184(1):452-65. PubMed ID: 19949105
[TBL] [Abstract][Full Text] [Related]
19. The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy.
Melichar B; Tousková M; Dvorák J; Jandík P; Kopecký O
Immunopharmacol Immunotoxicol; 2001 May; 23(2):163-73. PubMed ID: 11417845
[TBL] [Abstract][Full Text] [Related]
20. CD8
Dai SX; Gu HX; Lin QY; Huang SZ; Xing TS; Zhang QF; Wu G; Chen MH; Tan WE; Jian HJ; Zheng ZW; Zhong T; Zhang MH; Cheng XF; Huang P; Liao GJ; Sha WH
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):693-702. PubMed ID: 28502591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
